Business
BioMarin Pharmaceutical Inc., an unprofitable biotechnology company with one drug on the market, said it stopped testing of its experimental heart medicine Neutralase because of safety concerns.
Sept. 23, 2003
BioMarin Pharmaceutical Inc. said the Food and Drug Administration approved marketing of a therapy against a rare fatal genetic disorder.
June 2, 2005
Genzyme Corp. and BioMarin Pharmaceutical Inc. won European approval of their Aldurazyme treatment for a rare genetic disorder.
June 12, 2003
Science & Medicine
When their child was diagnosed with a genetic illness, Mark and Jeanne Dant raised more than $1 million for research. One of the scientists they funded developed an enzyme replacement that has dramatically helped their son.
Feb. 1, 2001
U.S. stocks notched their biggest gains in a week Thursday, pushing the Nasdaq composite index to an all-time high.
June 18, 2015
Pharmaceutical giant Pfizer Inc. is paying $14 billion to buy Medivation Inc., a San Francisco biotech company that sells a high-priced prostate cancer medication discovered by UCLA.
Aug. 22, 2016
Technology companies led U.S. stocks modestly higher Monday, driving the market to another set of milestones.
Dec. 11, 2017
Merger Suit Filed: Shareholders of Viratek Inc. and SPI Pharmaceuticals Inc. have filed two lawsuits in Delaware, where the companies are incorporated, seeking to block the companies’ proposed merger with ICN Pharmaceuticals Inc., which would create a $500-million company.
Aug. 5, 1994
Medicscript Inc., a pharmaceutical repackaging company based in Brea, has been acquired Summit Health Ltd., a Los Angeles-based health care company.
March 8, 1987
Obituaries
Rimmon C.
Jan. 4, 2008